Medical Biological Union, Ltd. (MBU) is one of the first privately held biotechnological companies in Russia. MBU works in the Health Science field. The company is focused on the development and realization of science-intensive projects resulting in commercialisation of novel products and technologies in the area of pharmaceutics, diagnostics, surgery, and personalized medicine to enhance a quality of human life and an availability of medical care. Researches and developments of MBU are aimed at making facilities and methods of reliable high q uality diagnostics of human diseases.
MBU, Ltd. was founded in 1992 in the Novosibirsk Scientific Center by a group of researchers and yang scientists. MBU, Ltd. started to manufacture ELISA kits and gained the Russian Federal License for Production, Storage and Realization of medical means, items for medical aids, and medical equipment. In a short time, the company has become one of the main players on the Russian market of diagnostic test kits and started extent its presence on the international markets, and first of all - on CIS markets. MBU is one of the leading manufacturers of diagnostic test kits in Russia and control material (panels of sera) for quality control of immunodiagnostics.
The performance (standard) panels manufactured by MBU, Ltd. were initially developed together with the Russian National Control and Research Agency–Tarasevich State Institute of Standardization and Control of Medical Biological Preparations. They are used by Russian regulatory agencies to test the quality of the test kits entering on Russian market as well as the working standards of diagnostic laboratories.
More than 100 highly skilled professionals are working at the MBU, Ltd.s R&D and Manufacturing Divisions, majority of them holding Ph.D. and M.Sc. degrees in life sciences. The MBU, Ltd.s product line is kept constantly extending by inclusion of developed IVDs products, which are offered into the market every year.
MBU is an integral part of the Novosibirsk Scientific Center and keeps its tight relations with scientific institutions located both in Novosibirsk and in other regions of Russia. The company participates in a number of joint projects with Novosibirsk Institute of Chemical Biology and Fundamental Medicine of SB RAS and State Research Center of Virology and Biotechnology Vector (SRC VB Vector).
MBU, Ltd. is one of the founders of Association Sibacademinnovation (Siberian Academic Innovations), which brings together innovational enterprises of the Novosibirsk Scientific Center, Presidium of the Siberian Branch of the Russian Academy of Sciences and State Foundation for Support of Science and Education at the Administration of Novosibirsk Region. A company is one of the first residents of Academpark (Technopark of Novosibirsk Academgorodok).
Now MBU, Ltd. is a headquarters of a MBU holding of innovation companies, and it is focused on identifying novel products and technologies and providing technology commercialization and marketing services to start-ups.
At a present time, MBU works in partnership with research institutes, venture foundations, industrial corporations, experts and consultants from Russia, USA, and Europe. The company operates and manages a portfolio of innovation projects, and it proposes to potential partners the partnership opportunities in the field of new products commercialization.
1992, August 31– MBU was established.
1993 – ELISA manufacturing facility was started up.
1994 – MBU launched HIV test kits on market. For the first time in Russia:
MBU started to manufacture the test kits with color-coded liquid components and color-control of sample addition to the plate wells;
Performance panels of human sera, recognized as the Russian National Immunobiological Standard with specific branch standard number, are developed and manufactured by MBU in joint project with Tarasevich State Institute of Standardization and Control of Medical Biological Preparations and State Research Center of Virology and Biotechnology “Vector”.
MBU started to distribute the test kits on the former USSR, CIS countries markets.
1996 - For the first time in Russia, MBU developed and manufactured the control panels of sera according to FSVOK and Tarasevich SISC requirements specification within the Federal programs on external quality control of laboratories dealing with infectious disease diagnostics and assessment of laboratory performance. MBU started as a prime partner and supplier of Russian Federal System of External Quality Assessment (FSVOK) for such control preparations.
1997 – MBU started to sale its products on international market.
2002 – MBU coupled with the enterprises of Academgorodok and took part in establishment of association “SibAcademInnovation” with the support and assistance of the Siberian branch of RAS and Novosibirsk administration.
2004 - MBU has represented in the USA by Medical Biological Union, LLC.
2005 - MBU test kit for the detection and quantitative determination of IgG antibodies to Measles virus “Measles-IgG-DS” has successfully passed the comparative and evaluation studies in laboratories of WHO network. Since 2005, MBU is permanent participant of Medica fair, Germany. Since 2005, MBU is permanent participant of Medica fair, Germany.
2005 - MBU, Ltd., Russia, and GloBus Consulting Services, Inc., USA, created strategic alliance aimed at expanding products and services offering on Russian and International biotech markets.
2006 – MBUs QMS was audited and certified according to ISO 9001.
2009 - MBU was one of the first residents of Academpark (Technopark of Novosibirsk Academgorodok).
2013 – MBUs headquarters moved to new building in Academpark area.